Advertisement

Ads Placeholder
Loading...

argenx SE

ARGNFPNK
Healthcare
Biotechnology
$712.03
$0.005(0.001%)
U.S. Market opens in 5h 1m

argenx SE (ARGNF) Stock Overview

Explore argenx SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap44.1B
P/E Ratio20.23
EPS (TTM)$19.58
ROE0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$841.14
3 Months$778.81
1 Year Target$887.72

ARGNF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of argenx SE (ARGNF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $887.72.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.23 and a market capitalization of 44.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-0.00%
1-Month Change
-12.63%
3-Month Change
-12.84%
6-Month Change
-14.57%
Year-to-Date (YTD) Change
-18.16%
1-Year Change
2.09%
3-Year Change
79.21%
5-Year Change
123.65%
All-Time (Max) Change
6866.98%

Contact Information

31 10 703 8441
Willemstraat 5, Breda, NaN, 4811 AH

Company Facts

15,990 Employees
IPO DateApr 30, 2015
CountryNL
Actively Trading

Frequently Asked Questions